Formosa Pharmaceuticals, Inc.

👨🔬 Dr. Erick Co, President & CEO at Formosa Pharmaceuticals, Inc., showcased our achievement in developing APP13007 using the APNT nanoparticle platform at the International Advanced Drug Delivery Symposium (IADDS) at National Tsing Hua University, Taiwan. 🏫 https://lnkd.in/g2uyYkRW #DrugDelivery #APNT #APP13007 #Nanotechnology

Thrilled to be visiting CPHI Milan this year! If you’re attending and would like to discuss potential collaborations, please don't hesitate to get in touch. Looking forward to connecting with partners, industry professionals, and exploring new opportunities. To Schedule a CPhI meeting with Formosa Pharmaceuticals, Inc.: https://shorturl.at/bvemV #APNT #ADCBiosimilar #APP13007 #OcularInflammation #CPhI

🎊 We are honored to share that Formosa Pharmaceuticals, Inc. (6838) has officially listed on the Taiwan Stock Exchange (TWSE) on August 13, 2024. ㊗ 我們非常榮幸地跟大家分享台新藥（6838）於2024年8月13日於臺灣證券交易所掛牌上市。 #APNT #APP13007 #6838 #TWSE

We are excited to announce the initiation of co-development between Formosa Pharmaceuticals, Inc. and Eyenovia, Inc.. Our collaboration aims to expand the indications for our APP13007 (Clobetasol Propionate Ophthalmic Suspension) to address Acute Dry Eye Disease in the U.S. This joint effort is a significant step towards helping millions of people who suffer from flare-ups due to Dry Eye Disease👁 . #APP13007 #FlareUp #Clobetasol #APNT #AcuteDryEye English News: https://shorturl.at/axr64

🍁We are thrilled to share that Formosa Pharmaceuticals, Inc. has officially executed a licensing agreement with Apotex Inc. The collaboration is set to focus on the commercialization of Clobetasol Propionate Ophthalmic Suspension (APP13007) for the Treatment of Inflammation and Pain Following Ocular Surgery specifically tailored for the Canadian market . Exciting developments ahead! 🍁 Link: https://shorturl.at/0zqp2 #Clobetalsol #APNT #APP13007 #OcularSurgery

✨Formosa Pharmaceuticals, Inc. 台新藥 BIO Asia-Taiwan 2024_Day 5 Highlight ! ✨ On behalf of employees and partners, Erick Co had the honor of meeting Taiwan Vice President, Bi-Khim (Louise) Hsiao 蕭美琴, at the BIO Asia–Taiwan Exhibition to celebrate Formosa Pharma’s Innovation of the Year award. ✨ The exhibition is extended through Monday, July 29, so there’s still time to visit Booth #M306 and meet us. Thank you for all the enthusiasm and support. #TaiwanBIOAwards #APP13007

✨ Formosa Pharmaceuticals, Inc. 台新藥 BIO Asia–Taiwan 2024_Day 3 Highlight ! ✨ 亞洲生技大展展覽攤位#M306 ✨ 亞洲生技大會開幕式暨傑出生技獎頒獎典禮 BIO Asia-Taiwan 2024 Opening and Taiwan BIO Awards Awarding Ceremony ✨ 公司展望說明會 Company Presentations

✨ BIO Asia–Taiwan 2024_Day 2 Highlight ! Dr. Erick Co, President and CEO of Formosa Pharmaceuticals, Inc. presented "APP13007: A Novel Ophthalmic Suspension of Clobetasol Propionate derived from APNT® Nanoparticle Formulation Technology, USFDA-approved for the Treatment of Inflammation and Pain Following Ocular Surgery" in Session 7 of Bio Asia-Taiwan Forum, Taiwan BIO Awards-Successful Stories. ✨ 亞洲生技大展第二天！亞洲生技大展論壇 Session 7 傑出生技獎廠商發表會 - 總經理許力克博士於論壇發表2024年度產業創新獎「APP13007: 以APNT®奈米微粒製劑技術開發並於美國獲准上市之用於治療眼科術後發炎疼痛之丙酸氯倍他索滴眼懸液」! 🌧 Due to the arrival of Typhoon Gaemi, the exhibition will be rescheduled to 7/26 (Friday) to 7/29 (Monday). We sincerely welcome partners and friends from all walks of life to visit our booth #M306 for exchange and communication! 🌧由於凱米颱風來襲，展覽部份變更為7/26（五）～7/29（一），誠摯歡迎各界夥伴及友人蒞臨展位#M306交流！

🌏 亞洲生技大展本週盛大舉行，台新藥(6838)將參與以下活動，誠摯邀請您與我們面對面交流。 🎉 🌏 BIO Asia-Taiwan is grandly held this week. Formosa Pharmaceuticals, Inc. will participate in the following activities and sincerely invite you to meet with us face-to-face. 🎉 ✨ 亞洲生技大展展覽 【攤位號碼】#M306 【日期/時間】：2024/7/25(四) - 7/28(日) 10:00 AM ~ 6:00 PM (最終日展至5:00 PM) 【Date】10:00 AM ~ 6:00 PM (Last day closes at 5:00 PM), July 25 (Thu.) - 28 (Sun.), 2024.   ✨ 亞洲生技大展晚宴 BIO Asia-Taiwan Banquet 【日期/時間】 2024年7月24日(三)／ 18:30-21:00  【地點】台北漢來大飯店3樓 鉑金B廳 (台北市南港區經貿一路168號3樓) 【Date】 July 24 (Wed.), 18:30 – 21:00 【Location】 GRAND HILAI TAIPEI, 3F, Platinum Grand Ballroom B (3F, NO. 168, JINGMAO 1ST RD., NANGANG DIST., TAIPEI, Taiwan (R.O.C.)   ✨ 亞洲生技大展論壇 Session 7 傑出生技獎廠商發表會 Forum: Session 7 Taiwan BIO Awards-Successful Stories 【日期/時間】 2024年7月25日(四)／ 10:45-12:15  【地點】台北南港展覽館一館4樓401會議室 【Date】 July 25 (Thu.), 10:45 – 12:15 【Location】 Room 401, 4F, TaiNEX Hall 1   ✨ 亞洲生技大會開幕式暨傑出生技獎頒獎典禮 BIO Asia-Taiwan 2024 Opening and Taiwan BIO Awards Awarding Ceremony 【日期/時間】 2024年7月26日(五)／ 15:30-16:30  【地點】台北世貿中心南港展覽館一館4樓 【Date】 July 25 (Thu.), 15:30 – 16:30 【Location】 4F, TaiNEX Hall 1   ✨ 公司展望說明會 Company Presentations 【日期/時間】 2024年7月26日(五)／ 10:15-10:30  【地點】台北世貿中心南港展覽館一館4樓402A 會議室 【Date】 July 25 (Thu.), 15:30 – 16:30 【Location】 Room 402A, 4F, TaiNEX Hall 1 近期新聞：台新藥啟動競拍 預計8月9日掛牌上市 https://lnkd.in/gm4KteYN #6838 #BIOAsiaTaiwan #TaiwanBioAward

台新藥宣布與Tzamal公司達成授權合約將治療眼部手術後的炎症和疼痛新藥APP13007於以色列市場之商業化。 中文新聞連結：https://shorturl.at/j5q27 We are pleased to announce that Formosa Pharmaceuticals, Inc. establishes this partnership with Tzamal Bio Pharma through an licensing agreement for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for Israel. #APP13007 #OcularSurgery #ClobetasolOphthalmicSuspension #APNT